Wanbury Limited
Wanbury Limited (WANBURY) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-09-02
Stock price
₹245.00
Market cap
854 Cr
Stock P/E
15.1
P/B
5.02
Dividend yield
0.4%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 133 Cr | 146 Cr | 144 Cr | 145 Cr | 139 Cr | 131 Cr | 161 Cr | 133 Cr | 172 Cr | 163 Cr | 160 Cr | 162 Cr |
| Operating expenses (approx.) | 119 Cr | 133 Cr | 127 Cr | 124 Cr | 121 Cr | 120 Cr | 141 Cr | 120 Cr | 142 Cr | 139 Cr | 134 Cr | 136 Cr |
| EBITDA | 14 Cr | 13 Cr | 17 Cr | 21 Cr | 18 Cr | 11 Cr | 20 Cr | 14 Cr | 30 Cr | 24 Cr | 26 Cr | 27 Cr |
| OPM % | 10.7% | 9.1% | 12.0% | 14.5% | 13.0% | 8.4% | 12.4% | 10.4% | 17.2% | 15.0% | 16.1% | 16.4% |
| Other income | -2 Cr | 0.62 Cr | 0.76 Cr | 0.69 Cr | 0.93 Cr | 0.94 Cr | 2 Cr | 0.84 Cr | 2 Cr | 0.35 Cr | 0.20 Cr | 0.18 Cr |
| Interest | 8 Cr | 6 Cr | 8 Cr | 8 Cr | 7 Cr | 8 Cr | 10 Cr | 10 Cr | 9 Cr | 8 Cr | 7 Cr | 7 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 4 Cr |
| Profit before tax | 0.92 Cr | 5 Cr | 7 Cr | 10 Cr | 34 Cr | 1 Cr | 8 Cr | 1 Cr | 19 Cr | 14 Cr | 15 Cr | 16 Cr |
| Tax % | -10.3% | 6.1% | -2.5% | -0.2% | 0.8% | 0.0% | 1.8% | 5.8% | -6.3% | 0.8% | -0.1% | 0.7% |
| Net profit | 1 Cr | 5 Cr | 7 Cr | 10 Cr | 34 Cr | 1 Cr | 8 Cr | 1 Cr | 20 Cr | 13 Cr | 15 Cr | 16 Cr |
| EPS (₹) | ₹0.80 | ₹1.43 | ₹2.25 | ₹3.13 | ₹12.75 | ₹0.32 | ₹2.44 | ₹0.76 | ₹6.18 | ₹4.12 | ₹4.58 | ₹4.52 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2018 | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 374 Cr | 374 Cr | 367 Cr | 393 Cr | 511 Cr | 500 Cr | 576 Cr | 600 Cr | Sign in for TTM |
| Operating expenses (approx.) | 442 Cr | 442 Cr | 344 Cr | 374 Cr | 476 Cr | 476 Cr | 506 Cr | 523 Cr | Sign in for TTM |
| EBITDA | -67 Cr | -68 Cr | 23 Cr | 18 Cr | 35 Cr | 23 Cr | 70 Cr | 76 Cr | Sign in for TTM |
| OPM % | -18.0% | -18.2% | 6.4% | 4.6% | 6.9% | 4.6% | 12.2% | 12.7% | Sign in for TTM |
| Other income | 76 Cr | 77 Cr | 1 Cr | 2 Cr | 2 Cr | 0.91 Cr | 3 Cr | 3 Cr | Sign in for TTM |
| Interest | 31 Cr | 31 Cr | 33 Cr | 23 Cr | 21 Cr | 21 Cr | 29 Cr | 37 Cr | Sign in for TTM |
| Depreciation | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 11 Cr | 12 Cr | 13 Cr | 13 Cr | Sign in for TTM |
| Profit before tax | -32 Cr | -32 Cr | 65 Cr | -12 Cr | 81 Cr | -10 Cr | 56 Cr | 30 Cr | Sign in for TTM |
| Tax % | 1.2% | 1.2% | 0.3% | -1.6% | -0.4% | -1.1% | 0.7% | -3.3% | Sign in for TTM |
| Net profit | -32 Cr | -32 Cr | 64 Cr | -13 Cr | 81 Cr | -10 Cr | 56 Cr | 31 Cr | Sign in for TTM |
| EPS (₹) | ₹-13.49 | ₹-13.49 | ₹26.90 | ₹-5.04 | ₹26.88 | ₹-6.18 | ₹26.39 | ₹9.32 | Sign in for TTM |
| Dividend payout % | — | — | — | — | 0.0% | — | 0.0% | 0.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2018 | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 24 Cr | 24 Cr | 25 Cr | 25 Cr | 33 Cr | 33 Cr | 33 Cr | 33 Cr |
| Reserves | -183 Cr | -233 Cr | -168 Cr | -181 Cr | -56 Cr | -66 Cr | -5 Cr | 27 Cr |
| Borrowings | 182 Cr | 208 Cr | 124 Cr | 88 Cr | 67 Cr | 64 Cr | 110 Cr | 173 Cr |
| Other liabilities | 248 Cr | 287 Cr | 298 Cr | 357 Cr | 309 Cr | 273 Cr | 206 Cr | 181 Cr |
| Total liabilities | 270 Cr | 286 Cr | 279 Cr | 289 Cr | 353 Cr | 304 Cr | 343 Cr | 414 Cr |
| Fixed assets (net) | 178 Cr | 172 Cr | 159 Cr | 158 Cr | 149 Cr | 152 Cr | 149 Cr | 190 Cr |
| CWIP | 10 Cr | 9 Cr | 14 Cr | 11 Cr | 2 Cr | 2 Cr | 3 Cr | 5 Cr |
| Investments | 0.02 Cr | 0.02 Cr | 0.0068 Cr | 0.01 Cr | 0.0093 Cr | 0.01 Cr | 0.03 Cr | 0.15 Cr |
| Inventories | 13 Cr | 19 Cr | 12 Cr | 25 Cr | 50 Cr | 22 Cr | 36 Cr | 38 Cr |
| Trade receivables | 29 Cr | 44 Cr | 51 Cr | 34 Cr | 63 Cr | 68 Cr | 89 Cr | 114 Cr |
| Cash & bank | 3 Cr | 3 Cr | 3 Cr | 10 Cr | 23 Cr | 1 Cr | 3 Cr | 4 Cr |
| Other assets | 37 Cr | 39 Cr | 40 Cr | 51 Cr | 66 Cr | 59 Cr | 63 Cr | 63 Cr |
| Total assets | 270 Cr | 286 Cr | 279 Cr | 289 Cr | 353 Cr | 304 Cr | 343 Cr | 414 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2018 | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | — | 38 Cr | 20 Cr | 4 Cr | 26 Cr |
| Cash from investing | — | — | — | — | 0.59 Cr | -9 Cr | -17 Cr | -51 Cr |
| Cash from financing | — | — | — | — | -26 Cr | -32 Cr | 15 Cr | 26 Cr |
| Net cash flow | — | — | — | — | 13 Cr | -21 Cr | 2 Cr | 0.66 Cr |
| Free cash flow (OCF − Capex) | — | — | — | — | 38 Cr | 20 Cr | -13 Cr | -23 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2018 | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | -343.2% | — | — | — | 54.7% | 34.4% | 62.0% | 28.6% |
| ROE % | — | — | — | — | — | — | 0.0% | 51.5% |
| Debtor days | 29 | 43 | 50 | 32 | 45 | 50 | 57 | 69 |
| Inventory days | 37 | 55 | 31 | 42 | 59 | 31 | 45 | 49 |
| Days payable | 232 | 318 | 304 | 228 | 229 | 210 | 205 | 181 |
| Cash conversion cycle | -166 | -220 | -223 | -154 | -125 | -129 | -103 | -63 |
| Debt / equity | 0.00 | — | — | — | — | — | 3.94 | 2.92 |
| Current ratio | 0.22 | 0.26 | 0.29 | 0.27 | 0.48 | 0.38 | 0.74 | 1.11 |
| Net debt / EBITDA | — | — | 0.00 | 0.00 | 0.00 | 2.70 | 1.52 | 2.22 |
Compare with peers
Loading peers…